Compare TOWN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | VCEL |
|---|---|---|
| Founded | 1998 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.0B |
| IPO Year | 1999 | 1997 |
| Metric | TOWN | VCEL |
|---|---|---|
| Price | $35.43 | $36.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $41.00 | ★ $60.40 |
| AVG Volume (30 Days) | 294.6K | ★ 579.0K |
| Earning Date | 01-21-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | 11.95 | ★ 236.54 |
| EPS | ★ 2.23 | 0.25 |
| Revenue | ★ $766,599,000.00 | $258,716,999.00 |
| Revenue This Year | $23.63 | $17.86 |
| Revenue Next Year | $29.20 | $18.55 |
| P/E Ratio | ★ $15.88 | $148.17 |
| Revenue Growth | ★ 14.10 | 14.05 |
| 52 Week Low | $29.43 | $29.24 |
| 52 Week High | $38.01 | $63.00 |
| Indicator | TOWN | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 69.02 | 45.31 |
| Support Level | $33.33 | $35.85 |
| Resistance Level | $35.68 | $42.68 |
| Average True Range (ATR) | 0.59 | 1.63 |
| MACD | 0.24 | -0.32 |
| Stochastic Oscillator | 93.73 | 12.60 |
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.